WallStreetZenWallStreetZen

AnalystsAndreas Argyrides
Andreas Argyrides's Stock Forecasts

Analyst Ranking
Top 34%
#1404 out of 4174 analysts
Average Return
+7.9%
Win Rate
71%5 out of 7
Risk vs Reward
Poor
Good

Andreas Argyrides's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Albireo Pharma IncALBO
+142.53%$18.08$43.85
2022-08-15 -
2023-01-09
Buy
Immunic IncIMUX
+8.75%$2.40$2.61
2023-01-30 -
2023-02-06
Buy
Pacira Biosciences IncPCRX
+5.02%$39.27$41.24
2023-01-30 -
2023-02-06
Buy
Ascendis Pharma AASND
+3.53%$110.26$114.15
2022-11-13 -
2023-02-06
Buy
Ars Pharmaceuticals IncSPRY
+2.19%$6.86$7.01
2023-01-30 -
2023-02-06
Buy

Andreas Argyrides Analyst Color

Get additional color on Andreas Argyrides's coverage of popular stocks

Andreas Argyrides's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Pacira Biosciences IncPCRX
1Buy$60.00+45.49%Assumes
7 days ago
Ars Pharmaceuticals IncSPRY
1Buy$10.00+42.65%Initiates Coverage On
7 days ago
Immunic IncIMUX
1Buy$5.00+91.57%Assumes
7 days ago
Biomarin Pharmaceutical IncBMRN
2Hold$83.00-26.01%Maintains
a month ago
Albireo Pharma IncALBO
2Hold$42.00-5.81%Downgrades
a month ago
Ascendis Pharma AASND
1Buy$164.00+43.67%Maintains
3 months ago
Gossamer Bio IncGOSS
1Buy$24.00+779.12%Initiates Coverage On
5 months ago
Global Blood Therapeutics IncGBT
1HoldN/AN/ADowngrades
6 months ago
Sangamo Therapeutics IncSGMO
1Hold$5.00+44.51%Assumes
8 months ago
Rani Therapeutics Holdings IncRANI
1Buy$28.00+378.63%Initiates Coverage On
8 months ago
Regenxbio IncRGNX
1Hold$29.00N/AInitiates Coverage On
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.